FR08C0052I2 - Derives de 6-mercapto-cyclodextrine: agents d'inversion du blocage neuromusculaire provoque par des substances medicamenteuses - Google Patents

Derives de 6-mercapto-cyclodextrine: agents d'inversion du blocage neuromusculaire provoque par des substances medicamenteuses

Info

Publication number
FR08C0052I2
FR08C0052I2 FR08C0052C FR08C0052C FR08C0052I2 FR 08C0052 I2 FR08C0052 I2 FR 08C0052I2 FR 08C0052 C FR08C0052 C FR 08C0052C FR 08C0052 C FR08C0052 C FR 08C0052C FR 08C0052 I2 FR08C0052 I2 FR 08C0052I2
Authority
FR
France
Prior art keywords
mercapto
agents
drug substances
cyclodextrin derivatives
blockage caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR08C0052C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8241767&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR08C0052(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon NV filed Critical Organon NV
Publication of FR08C0052I1 publication Critical patent/FR08C0052I1/fr
Application granted granted Critical
Publication of FR08C0052I2 publication Critical patent/FR08C0052I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR08C0052C 1999-11-29 2008-12-30 Derives de 6-mercapto-cyclodextrine: agents d'inversion du blocage neuromusculaire provoque par des substances medicamenteuses Active FR08C0052I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99309558 1999-11-29
PCT/EP2000/011789 WO2001040316A1 (en) 1999-11-29 2000-11-23 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
EP00993261A EP1259550B1 (en) 1999-11-29 2000-11-23 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block

Publications (2)

Publication Number Publication Date
FR08C0052I1 FR08C0052I1 (forum.php) 2009-02-27
FR08C0052I2 true FR08C0052I2 (fr) 2009-12-18

Family

ID=8241767

Family Applications (1)

Application Number Title Priority Date Filing Date
FR08C0052C Active FR08C0052I2 (fr) 1999-11-29 2008-12-30 Derives de 6-mercapto-cyclodextrine: agents d'inversion du blocage neuromusculaire provoque par des substances medicamenteuses

Country Status (33)

Country Link
US (3) US6670340B1 (forum.php)
EP (1) EP1259550B1 (forum.php)
JP (2) JP3880041B2 (forum.php)
KR (1) KR100716524B1 (forum.php)
CN (1) CN1188428C (forum.php)
AR (1) AR026605A1 (forum.php)
AT (1) ATE288450T1 (forum.php)
AU (1) AU776536B2 (forum.php)
BE (1) BE2008C047I2 (forum.php)
BR (1) BRPI0015947B8 (forum.php)
CA (1) CA2390463C (forum.php)
CO (1) CO5251450A1 (forum.php)
CY (1) CY2008018I1 (forum.php)
CZ (1) CZ298206B6 (forum.php)
DE (2) DE122008000068I2 (forum.php)
DK (1) DK1259550T3 (forum.php)
ES (1) ES2237496T3 (forum.php)
FR (1) FR08C0052I2 (forum.php)
HU (1) HU227451B1 (forum.php)
IL (1) IL149423A0 (forum.php)
LU (1) LU91501I2 (forum.php)
MX (1) MXPA02004940A (forum.php)
NL (1) NL300356I2 (forum.php)
NO (2) NO328790B1 (forum.php)
NZ (1) NZ518752A (forum.php)
PE (1) PE20010902A1 (forum.php)
PL (1) PL203012B1 (forum.php)
PT (1) PT1259550E (forum.php)
RU (1) RU2260013C2 (forum.php)
SK (1) SK286282B6 (forum.php)
TW (1) TWI242015B (forum.php)
WO (1) WO2001040316A1 (forum.php)
ZA (1) ZA200203538B (forum.php)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6744471B1 (en) * 1997-12-05 2004-06-01 Olympus Optical Co., Ltd Electronic camera that synthesizes two images taken under different exposures
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
ATE337790T1 (de) * 2000-11-02 2006-09-15 Akzo Nobel Nv Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen
JP2007523887A (ja) 2003-10-31 2007-08-23 ザ・ユニヴァーシティ・オブ・カンザス スルホアルキルエーテル−アルキルエーテルシクロデキストリン誘導体
US7851457B2 (en) 2004-01-29 2010-12-14 Innovative Biologics, Inc. β-Cyclodextrin derivatives
DK2708225T3 (en) 2004-04-23 2019-04-08 Cydex Pharmaceuticals Inc DPI formulation containing sulfoalkyl ether cyclodextrin
CN101151037A (zh) 2005-01-28 2008-03-26 平纳克尔医药股份有限公司 作为抗菌剂的β-环糊精衍生物
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
ES2526903T3 (es) 2005-10-26 2015-01-16 Cydex Pharmaceuticals, Inc. Composiciones de sulfoalquiléter ciclodextrina y métodos de preparación de las mismas
US20090069412A1 (en) * 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched sugammadex
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
US7938283B2 (en) * 2008-06-20 2011-05-10 Grainpro, Inc. System and method for hermetic storage of agricultural commodities during shipping
US10463677B2 (en) 2008-11-07 2019-11-05 Cydex Pharmaceuticals, Inc. Composition containing sulfoalkyl ether cyclodextrin and latanoprost
CN101591402B (zh) * 2009-05-05 2011-11-30 杭州奥默医药技术有限公司 6-脱氧砜类环糊精衍生物及其制备方法
US8492538B1 (en) 2009-06-04 2013-07-23 Jose R. Matos Cyclodextrin derivative salts
DE102010012281A1 (de) * 2010-03-22 2011-09-22 Fresenius Medical Care Deutschland Gmbh Pharmazeutische Zusammensetzungen enthaltend substituiertes 6-Deoxy-6-sulfanylcyclodextrin
CN101864003B (zh) * 2010-06-11 2012-05-02 漆又毛 一种6-脱氧硫醚氨基酸环糊精衍生物的合成方法
WO2012025937A1 (en) * 2010-08-25 2012-03-01 Ramamohan Rao Davuluri Improved process for preparation of sugammadex
CN102060941B (zh) 2010-11-26 2012-12-26 漆又毛 6-脱氧α-氨基酸衍生物环糊精及制备和应用
DK2814849T3 (da) 2012-02-15 2020-03-09 Cydex Pharmaceuticals Inc Fremgangsmåde til fremstilling af cyclodextrin-derivater
CN110066351B (zh) 2012-02-28 2022-06-14 锡德克斯药物公司 烷基化环糊精组合物及其制备和使用方法
JP5892847B2 (ja) * 2012-04-27 2016-03-23 Ｄｏｗａホールディングス株式会社 シクロデキストリンとシリカ含有物質との複合材料、及びその製造方法、並びにガス吸着剤
GB201211153D0 (en) * 2012-06-22 2012-08-08 Farmhispania Pharmaceutical compositions
UA121095C2 (uk) 2012-10-22 2020-04-10 Сідекс Фармасьютікалс, Інк. Композиції алкілованого циклодекстрину і способи їх одержання і застосування
EP2956486B1 (en) * 2013-02-14 2020-09-30 Neuland Laboratories Ltd An improved process for preparation of sugammadex sodium
WO2015179963A1 (en) 2014-05-29 2015-12-03 Uti Limited Partnership Cyclodextrin-based polyanionic and non-ionic dendrimers
RU2705996C2 (ru) 2014-06-26 2019-11-13 Маруиси Фармасьютикал Ко., Лтд. Препарат рокурония с улучшенной стабильностью
CN105348412B (zh) * 2014-08-22 2018-06-05 江苏恩华药业股份有限公司 一种舒更葡糖钠的纯化方法
WO2016029179A1 (en) 2014-08-22 2016-02-25 Cydex Pharmaceuticals, Inc. Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same
ES3029362T3 (en) 2015-03-19 2025-06-24 Cydex Pharmaceuticals Inc Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same
CN104844732B (zh) * 2015-03-27 2017-05-03 山东滨州智源生物科技有限公司 一种舒更葡糖钠的制备方法
JP2018510912A (ja) * 2015-04-08 2018-04-19 リン，チャン−チュン ポリアニオン性および非イオン性のシクロデキストリン系デンドリマーの医薬組成物およびその使用
CN107849157A (zh) * 2015-05-29 2018-03-27 拉克什米·普拉萨德·阿拉帕斯 制备舒更葡糖及其中间体的方法
CN104922693A (zh) * 2015-06-19 2015-09-23 南开大学 一种阴离子型环糊精与抗癌药物包合物及制备方法
AU2016334062A1 (en) * 2015-10-07 2018-05-10 Uti Limited Partnership Multifunctional polyanionic cyclodextrin dendrimers
EP3741801A1 (en) 2015-11-25 2020-11-25 Fresenius Kabi iPSUM S.r.l. Crystalline forms of per-chloro-gamma-cyclodextrines
WO2017089966A1 (en) 2015-11-25 2017-06-01 Fresenius Kabi Antiinfectives S.R.L. An improved process for the preparation of sugammadex and its intermediates
SI3433285T1 (sl) 2016-03-22 2020-10-30 Fresenius Kabi Ipsum S.R.L. Izboljšan postopek za pripravo sugamadeksa
DK3448395T3 (da) * 2016-04-29 2020-06-02 Alveron Pharma B V Cyclodextriner som prokoagulanter
HRP20220705T1 (hr) 2016-06-23 2022-07-22 Synthon B.V. Postupak dobivanja sugamadeksa
EP3421503B1 (en) * 2016-06-29 2020-05-20 Beijing Creatron Institute Of Pharmaceutical Research Co., Ltd. Sugammadex preparation and purification method
US10526422B2 (en) 2016-06-29 2020-01-07 Beijing Creatron Institute Of Pharmaceutical Research Co., Ltd. Process for preparation and purification of Sugammades sodium
CN107778383B (zh) * 2016-08-24 2020-03-10 王炳永 一种舒更葡糖钠的精制方法
US10385142B2 (en) 2017-01-23 2019-08-20 Scinopharm Taiwan, Ltd. Method for preparing sugammadex sodium
EP3618825A4 (en) 2017-05-03 2021-01-20 Cydex Pharmaceuticals, Inc. COMPOSITION CONTAINING CYCLODEXTRIN AND BUSULFAN
CN109021148B (zh) * 2017-06-08 2020-11-10 天津科伦药物研究有限公司 一种制备舒更葡糖钠的方法
US10442871B2 (en) * 2017-06-22 2019-10-15 Lawrence Livermore National Security, Llc Modified cyclodextrins for the selective sequestration of fentanyl related compounds and uses thereof
ES2761899T3 (es) 2017-06-30 2020-05-21 Synthon Bv Proceso para preparar Sugammadex
US10233263B1 (en) * 2017-08-23 2019-03-19 Formosa Laboratories, Inc. Method for preparation of sugammadex sodium
TWI703163B (zh) * 2017-08-23 2020-09-01 台耀化學股份有限公司 舒更葡糖鈉之製備方法及其晶型
WO2019102009A1 (en) 2017-11-27 2019-05-31 Medichem, S.A. Process for the synthesis of a cyclodextrin derivative
CN107892727B (zh) * 2017-11-27 2019-12-24 合肥博思科创医药科技有限公司 一种舒更葡糖钠的纯化方法
HRP20220728T1 (hr) 2018-04-06 2022-08-05 Synthon B.V. Pročišćavanje sugamadeksa
KR102054228B1 (ko) 2018-05-28 2019-12-10 연성정밀화학(주) 슈가마덱스 나트륨염의 제조방법
WO2019236436A1 (en) * 2018-06-07 2019-12-12 Merck Sharp & Dohme Corp. Processes for the preparation of sugammadex
CN110615860A (zh) * 2018-06-20 2019-12-27 江苏恒瑞医药股份有限公司 一种舒更葡糖钠的纯化方法
WO2020028448A1 (en) 2018-08-02 2020-02-06 Pliva Hrvatska D.O.O. Solid state forms of sugammadex sodium
US11845811B2 (en) 2018-09-20 2023-12-19 Natco Pharma Limited Process for the preparation of Sugammadex sodium and its novel polymorphic form
EP3856791A1 (en) * 2018-09-27 2021-08-04 Werthenstein Biopharma GmbH Novel crystalline forms of sugammadex
JP6950966B2 (ja) * 2018-11-01 2021-10-13 丸石製薬株式会社 スガマデクス又はその薬理学的に許容される塩含有液剤及びその製造方法
CN109438591B (zh) * 2018-12-29 2021-02-09 博瑞生物医药（苏州）股份有限公司 舒更葡糖钠的制备工艺
CN109824800A (zh) * 2018-12-29 2019-05-31 鼎元(天津)生物医药科技有限公司 一种选择性肌松拮抗药舒更葡萄糖钠的制备方法
WO2020201930A1 (en) 2019-03-29 2020-10-08 Hospira, Inc. An improved process for preparation of sugammadex acid and sugammadex sodium
CN111978435B (zh) 2019-05-22 2021-05-25 合肥博思科创医药科技有限公司 一种高纯度舒更葡糖钠的制备方法
US11324692B2 (en) 2019-07-03 2022-05-10 Galenicum Health S.L.U. Method to prepare pharmaceutical compositions of suggamadex
WO2021039084A1 (ja) 2019-08-30 2021-03-04 テルモ株式会社 注射液製剤
RU2724900C1 (ru) * 2019-10-24 2020-06-26 Маруиси Фармасьютикал Ко., Лтд. Препарат рокурония с улучшенной стабильностью
CN111019016B (zh) * 2019-12-27 2022-02-18 武汉嘉诺康医药技术有限公司 一种舒更葡糖钠杂质的合成方法
JP2023515087A (ja) 2020-02-28 2023-04-12 メディチェム エセ．ア． スガマデクスを乾燥させるための方法
CN111714459B (zh) * 2020-06-18 2022-06-14 广州瑞尔医药科技有限公司 一种注射用舒更葡糖钠粉针剂及其制备方法
US11097023B1 (en) 2020-07-02 2021-08-24 Par Pharmaceutical, Inc. Pre-filled syringe containing sugammadex
EP3932391A1 (en) 2020-07-03 2022-01-05 Galenicum Health S.L.U. Method to prepare pharmaceutical compositions
US11446325B2 (en) * 2020-09-30 2022-09-20 Cyclolab Cyclodextrin Research And Development Laboratory Ltd. Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases
US11945788B2 (en) 2021-06-07 2024-04-02 Nuray Chemicals Private Limited Process for preparing pitolisant hydrochloride and solid-state forms thereof
CN113637097A (zh) * 2021-08-10 2021-11-12 北京恒创星远医药科技有限公司 6-全脱氧-6-全碘代-γ-环糊精晶体及其制备方法和应用
CN120392546A (zh) 2021-08-19 2025-08-01 北京费森尤斯卡比医药有限公司 包含巯基环糊精衍生物或其可药用盐的包装药品和保存方法
CN119679816A (zh) * 2023-09-15 2025-03-25 杭州奥默医药股份有限公司 一种用于逆转苄异喹啉类肌松药的肌松拮抗药物

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929813A (en) 1973-12-26 1975-12-30 Interx Research Corp Novel pro-drug derivatives of pyridinium aldoxime type cholinesterase reactivators and process for preparing same
JPS52108027A (en) 1976-03-09 1977-09-10 Rikagaku Kenkyusho Anticarcinogen
US4816462A (en) 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
HU194858B (en) 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
IT1196033B (it) 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
GB8506792D0 (en) 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
GB8613688D0 (en) 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0819004B2 (ja) 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
HU201783B (en) 1987-10-13 1990-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing partially methylized carboxy-acyl-beta-cyclodextrines and salts
US5002935A (en) 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5017566A (en) 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5173481A (en) 1989-04-03 1992-12-22 The United States Of America As Represented By The Department Of Health And Human Services Preparation of specifically substituted cyclodextrins
DK0465535T3 (da) 1989-04-03 1999-03-01 Janssen Pharmaceutica Nv Regioselektive substitutioner i cyclodextriner
SU1703657A1 (ru) * 1990-01-23 1992-01-07 Пятигорский фармацевтический институт Соединение включени диэтиламида никотиновой кислоты и @ -циклодекстрина, про вл ющее пролонгированное аналептическое действие
ES2067854T3 (es) 1990-03-15 1995-04-01 Tanabe Seiyaku Co Polisulfato de derivado de ciclodextrina y procedimiento para preparar el mismo.
US5180716A (en) 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
US5180176A (en) * 1991-08-08 1993-01-19 Far Great Plastics Industrial Co., Ltd. Elastic truck for roller skates
JP2556236B2 (ja) 1991-08-29 1996-11-20 田辺製薬株式会社 β−シクロデキストリン誘導体のポリ硫酸エステル及びその製法
US5840881A (en) 1992-11-27 1998-11-24 Takeda Chemical Industries, Ltd. Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility
US5767112A (en) 1994-10-21 1998-06-16 Poli Industria Chimica, S.P.A. Muscle relaxant pharmaceutical compositions
AU708107B2 (en) 1994-11-04 1999-07-29 Commonwealth Scientific And Industrial Research Organisation Method for treating animals
GB2307176A (en) * 1995-11-15 1997-05-21 Todd Selwyn Everest Anti-inflammatory clathrating agents for topical use
US5935941A (en) 1997-10-24 1999-08-10 Pitha; Josef Alkylations of cyclodextrins leading to derivatives which have a ridgidly extended cavity
US5834446A (en) * 1996-06-21 1998-11-10 Queen's University At Kingston Nerve process growth modulators
JP4249282B2 (ja) 1998-02-27 2009-04-02 日本食品化工株式会社 新規シクロデキストリン誘導体及びその製造方法
JP4817495B2 (ja) 1998-05-29 2011-11-16 ニューロサイエンシーズ・リサーチ・ファウンデーション・インコーポレーテッド 外因性カンナビノイドでの痛みの制御
CN1241576C (zh) 1999-08-13 2006-02-15 阿克佐诺贝尔公司 化学螯合剂用于制备逆转临床使用的神经肌肉传导阻滞剂药物诱发的神经肌肉传导阻滞的药物的用途
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
US20020111377A1 (en) 2000-12-22 2002-08-15 Albany College Of Pharmacy Transdermal delivery of cannabinoids
JP4313041B2 (ja) 2001-02-14 2009-08-12 ナームローゼ・フエンノートチヤツプ・オルガノン ２−アルキル化−シクロデキストリン誘導体：薬物性神経筋遮断に対する拮抗薬
TW200402417A (en) 2002-06-21 2004-02-16 Akzo Nobel Nv 1-[(Indol-3-yl)carbonyl]piperazine derivatives

Also Published As

Publication number Publication date
DE122008000068I1 (de) 2009-04-23
CZ298206B6 (cs) 2007-07-18
LU91501I2 (fr) 2009-01-26
PE20010902A1 (es) 2001-09-06
BE2008C047I2 (forum.php) 2019-12-11
CO5251450A1 (es) 2003-02-28
JP2003515623A (ja) 2003-05-07
CZ20021814A3 (cs) 2002-08-14
DE60017947T2 (de) 2005-06-23
IL149423A0 (en) 2002-11-10
NL300356I2 (nl) 2009-04-01
PL356097A1 (en) 2004-06-14
NZ518752A (en) 2003-03-28
JP2006348301A (ja) 2006-12-28
HUP0203755A3 (en) 2003-10-28
NO2010019I1 (no) 2010-11-22
USRE44733E1 (en) 2014-01-28
BRPI0015947B1 (pt) 2012-02-07
ATE288450T1 (de) 2005-02-15
EP1259550A1 (en) 2002-11-27
KR20020063900A (ko) 2002-08-05
NO20022522L (no) 2002-05-28
KR100716524B1 (ko) 2007-05-10
JP3880041B2 (ja) 2007-02-14
CN1402737A (zh) 2003-03-12
US6670340B1 (en) 2003-12-30
HU227451B1 (en) 2011-06-28
HK1049489A1 (en) 2003-05-16
JP4563972B2 (ja) 2010-10-20
DE60017947D1 (de) 2005-03-10
PT1259550E (pt) 2005-05-31
EP1259550B1 (en) 2005-02-02
CA2390463A1 (en) 2001-06-07
NO328790B1 (no) 2010-05-18
NL300356I1 (nl) 2008-10-01
PL203012B1 (pl) 2009-08-31
DE122008000068I2 (de) 2011-06-16
SK7262002A3 (en) 2002-11-06
CY2008018I2 (el) 2009-11-04
SK286282B6 (sk) 2008-06-06
WO2001040316A1 (en) 2001-06-07
TWI242015B (en) 2005-10-21
MXPA02004940A (es) 2003-05-23
RU2260013C2 (ru) 2005-09-10
CA2390463C (en) 2009-02-03
US6949527B2 (en) 2005-09-27
US20040029833A1 (en) 2004-02-12
ZA200203538B (en) 2003-08-04
BRPI0015947B8 (pt) 2021-07-06
LU91501I9 (forum.php) 2019-01-02
BRPI0015947A (pt) 2002-08-20
CN1188428C (zh) 2005-02-09
AR026605A1 (es) 2003-02-19
NO20022522D0 (no) 2002-05-28
NO2010019I2 (no) 2012-08-27
FR08C0052I1 (forum.php) 2009-02-27
ES2237496T3 (es) 2005-08-01
AU5438001A (en) 2001-06-12
DK1259550T3 (da) 2005-04-25
HUP0203755A2 (hu) 2003-04-28
AU776536B2 (en) 2004-09-16
CY2008018I1 (el) 2009-11-04

Similar Documents

Publication Publication Date Title
FR08C0052I2 (fr) Derives de 6-mercapto-cyclodextrine: agents d'inversion du blocage neuromusculaire provoque par des substances medicamenteuses
FR15C0086I2 (fr) Derives d'hydroxamate en tant qu'inhibiteurs de desacetylase
FR15C0096I2 (fr) Derives carbamoyloxyalkyl-azolium n-substitues
MA26816A1 (fr) Derives d'amino-triazolopyridine
NO20004392L (no) Produkt for personlig hygiene med forbedret duft
MA25433A1 (fr) Derives d'arylmethyl-carbonylamino-thiazole, leur procede de preparation et leur utilisation en tant qu'agents antitumoraux
NL300385I1 (nl) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases.
PT1163237E (pt) Derivados de amida
EE200000574A (et) Farmatseutilised ühendid angiogeensete häirete kuvamiseks
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
NL1014545A1 (nl) Oxim-derivaten en de toepassing daarvan als latente zuren.
MA26831A1 (fr) Derives de benzodiazepine."
MA26848A1 (fr) Derives d'heterocyclo-alkylsufonylpyrazole nouveaux servant d'agents anti-inflammatoires/analgesiques.
CY1109334T1 (el) Παραγωγα ν-αλκοξυαλκυλο-ν,ν-διαλκυλαμινης ή αλατα αυτης και φαρμακα δια νευρο-εκφυλιστικας νοσους περιεχοντα αυτα
EE200100422A (et) Epotilooni derivaadid, nende valmistamismeetod jafarmatseutiline kasutamine
EP1167375A4 (en) ERYTHROMYCIN DERIVATIVES
EE200100445A (et) Suitsetatav toode
FR2792529B1 (fr) Nouvelles compositions pharmaceutiques comprenant des derives de 2-isoxazole-8-aminotetralines
PT1153014E (pt) Derivados de beta-alanina
GB0026578D0 (en) Heterocyclic derivatives useful as pharmaceutical agents
FR2802207B1 (fr) Derives de l'isosorbide utilisables dans des compositions detergentes pour carburants de type essence
ITMI20001848A0 (it) Faramaci per l'incontinenza.
MA25653A1 (fr) Derives d'amides heterocycliques.
FR2800360B1 (fr) Distributeur de melange de produit extemporane
FR2798820B1 (fr) Dispositif pour desenliser des tables d'elevage de coquillages